Skip to content

Celcuity CELC Long-Term Debt

Long-Term Debt at other companies

Eli Lilly logo
Eli LillyLLY
$39.37B+14.1%
Gilead Sciences logo
Gilead SciencesGILD
$20.86B-5.8%
CG Oncology logo
CG OncologyCGON
$3M
CRISPR Therapeutics logo
CRISPR TherapeuticsCRSP
$585.47M
Tenet Healthcare logo
Tenet HealthcareTHC
$13.21B+0.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:LongTermDebt.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's long-term debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's long-term debt?
Celcuity (CELC) reported long-term debt of $137.87M in Q1 2026.
How has Celcuity's long-term debt changed year-over-year?
Celcuity's long-term debt increased by 30.9% year-over-year, from $105.34M to $137.87M.
What is the long-term trend for Celcuity's long-term debt?
Over 4 years (2021 to 2025), Celcuity's long-term debt has grown at a 71.3% compound annual growth rate (CAGR), from $15.98M to $137.55M.
What does long-term debt mean?
Bonds, term loans, notes payable, and other borrowings with maturities beyond one year — the primary long-term financing source.